Pacific Edge share price jumps on Medicare coverage announcement

Pacific Edge share price jumps on Medicare coverage announcement
The jury is still out on Medicare coverage for Pacific Edge's cancer test. (Image: Pacific Edge)
Staff reporters
Cancer diagnostic company Pacific Edge (PEB) saw its share price jump after trading resumed on Thursday morning following an announcement concerning coverage by US insurers.At midday, the share was trading at 21 cents, up 123.4%.In a market announcement on Thursday, the company said it welcomed a decision by Novitas and First Coast to delay the implementation of the local coverage determination (LCD) released in early June that would have seen Medicare coverage of Cxbladder cease in the US on 17 July 2023.Pacific Edge has spent years trying to...